Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Short-term Investments (2022 - 2025)

Definitive Healthcare (DH) has disclosed Short-term Investments for 4 consecutive years, with $17.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 13820.97% year-over-year to $17.3 million, compared with a TTM value of $17.3 million through Dec 2025, up 13820.97%, and an annual FY2025 reading of $17.3 million, up 13820.97% over the prior year.
  • Short-term Investments was $17.3 million for Q4 2025 at Definitive Healthcare, down from $94.6 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $229.6 million in Q3 2023 and bottomed at $124000.0 in Q4 2024.
  • Average Short-term Investments over 4 years is $144.4 million, with a median of $171.7 million recorded in 2024.
  • The sharpest move saw Short-term Investments plummeted 99.93% in 2024, then soared 13820.97% in 2025.
  • Year by year, Short-term Investments stood at $184.9 million in 2022, then decreased by 4.24% to $177.1 million in 2023, then tumbled by 99.93% to $124000.0 in 2024, then skyrocketed by 13820.97% to $17.3 million in 2025.
  • Business Quant data shows Short-term Investments for DH at $17.3 million in Q4 2025, $94.6 million in Q1 2025, and $124000.0 in Q4 2024.